NUVASIVE INC (NUVA) Fundamental Analysis & Valuation

NASDAQ:NUVA • US6707041058

Current stock price

39.75 USD
-0.91 (-2.24%)
At close:
39.88 USD
+0.13 (+0.33%)
After Hours:

This NUVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. NUVA Profitability Analysis

1.1 Basic Checks

  • NUVA had positive earnings in the past year.
  • NUVA had a positive operating cash flow in the past year.
NUVA Yearly Net Income VS EBIT VS OCF VS FCFNUVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M 150M 200M

1.2 Ratios

  • NUVA has a better Return On Assets (1.36%) than 75.38% of its industry peers.
  • NUVA has a Return On Equity of 3.19%. This is in the better half of the industry: NUVA outperforms 76.38% of its industry peers.
  • With a decent Return On Invested Capital value of 3.43%, NUVA is doing good in the industry, outperforming 76.38% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for NUVA is significantly below the industry average of 9.15%.
  • The last Return On Invested Capital (3.43%) for NUVA is above the 3 year average (2.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.36%
ROE 3.19%
ROIC 3.43%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.87%
ROIC(5y)3.87%
NUVA Yearly ROA, ROE, ROICNUVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 5 -5 10

1.3 Margins

  • NUVA has a Profit Margin of 2.32%. This is in the better half of the industry: NUVA outperforms 74.37% of its industry peers.
  • In the last couple of years the Profit Margin of NUVA has declined.
  • NUVA has a better Operating Margin (6.73%) than 74.87% of its industry peers.
  • In the last couple of years the Operating Margin of NUVA has declined.
  • NUVA has a better Gross Margin (71.66%) than 82.41% of its industry peers.
  • In the last couple of years the Gross Margin of NUVA has remained more or less at the same level.
Industry RankSector Rank
OM 6.73%
PM (TTM) 2.32%
GM 71.66%
OM growth 3Y-12.51%
OM growth 5Y-9.94%
PM growth 3Y-15.55%
PM growth 5Y-15.81%
GM growth 3Y-0.57%
GM growth 5Y-0.5%
NUVA Yearly Profit, Operating, Gross MarginsNUVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. NUVA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUVA is destroying value.
  • NUVA has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, NUVA has an improved debt to assets ratio.
NUVA Yearly Shares OutstandingNUVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
NUVA Yearly Total Debt VS Total AssetsNUVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 1.91 indicates that NUVA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.91, NUVA is in line with its industry, outperforming 57.29% of the companies in the same industry.
  • A Debt/Equity ratio of 0.89 indicates that NUVA is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.89, NUVA is not doing good in the industry: 78.89% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.91
ROIC/WACC0.42
WACC8.11%
NUVA Yearly LT Debt VS Equity VS FCFNUVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.25 indicates that NUVA should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.25, NUVA is doing worse than 89.45% of the companies in the same industry.
  • A Quick Ratio of 0.65 indicates that NUVA may have some problems paying its short term obligations.
  • NUVA has a worse Quick ratio (0.65) than 93.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.65
NUVA Yearly Current Assets VS Current LiabilitesNUVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. NUVA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 15.61% over the past year.
  • The Earnings Per Share has been growing slightly by 0.62% on average over the past years.
  • The Revenue has been growing slightly by 4.44% in the past year.
  • The Revenue has been growing slightly by 3.20% on average over the past years.
EPS 1Y (TTM)15.61%
EPS 3Y-7.23%
EPS 5Y0.62%
EPS Q2Q%19.15%
Revenue 1Y (TTM)4.44%
Revenue growth 3Y0.96%
Revenue growth 5Y3.2%
Sales Q2Q%2.36%

3.2 Future

  • NUVA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.32% yearly.
  • Based on estimates for the next years, NUVA will show a small growth in Revenue. The Revenue will grow by 6.89% on average per year.
EPS Next Y13.97%
EPS Next 2Y14.82%
EPS Next 3Y14.9%
EPS Next 5Y14.32%
Revenue Next Year6.01%
Revenue Next 2Y6.22%
Revenue Next 3Y6.45%
Revenue Next 5Y6.89%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NUVA Yearly Revenue VS EstimatesNUVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
NUVA Yearly EPS VS EstimatesNUVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

5

4. NUVA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.88, the valuation of NUVA can be described as rather expensive.
  • Based on the Price/Earnings ratio, NUVA is valued cheaper than 86.93% of the companies in the same industry.
  • NUVA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.18, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 15.23, which indicates a correct valuation of NUVA.
  • NUVA's Price/Forward Earnings ratio is rather cheap when compared to the industry. NUVA is cheaper than 88.44% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.96, NUVA is valued rather cheaply.
Industry RankSector Rank
PE 19.88
Fwd PE 15.23
NUVA Price Earnings VS Forward Price EarningsNUVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 93.47% of the companies in the same industry are more expensive than NUVA, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11
NUVA Per share dataNUVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as NUVA's earnings are expected to grow with 14.90% in the coming years.
PEG (NY)1.42
PEG (5Y)32.2
EPS Next 2Y14.82%
EPS Next 3Y14.9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NUVA Dividend Analysis

5.1 Amount

  • NUVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NUVA Fundamentals: All Metrics, Ratios and Statistics

NUVASIVE INC

NASDAQ:NUVA (8/31/2023, 8:10:26 PM)

After market: 39.88 +0.13 (+0.33%)

39.75

-0.91 (-2.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-02
Earnings (Next)11-07
Inst Owners0%
Inst Owner Change0%
Ins Owners1.99%
Ins Owner Change0%
Market Cap2.08B
Revenue(TTM)1.23B
Net Income(TTM)28.45M
Analysts70.91
Price Target50.72 (27.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.04%
Min EPS beat(2)0.41%
Max EPS beat(2)7.68%
EPS beat(4)2
Avg EPS beat(4)-2.68%
Min EPS beat(4)-17.19%
Max EPS beat(4)7.68%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.05%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)1.16%
Revenue beat(4)1
Avg Revenue beat(4)-2.23%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.16%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.53%
PT rev (3m)2.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.88%
EPS NY rev (1m)0%
EPS NY rev (3m)2.33%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.88
Fwd PE 15.23
P/S 1.7
P/FCF N/A
P/OCF 14.94
P/B 2.34
P/tB 24.74
EV/EBITDA 11
EPS(TTM)2
EY5.03%
EPS(NY)2.61
Fwd EY6.57%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)2.66
OCFY6.69%
SpS23.38
BVpS17.02
TBVpS1.61
PEG (NY)1.42
PEG (5Y)32.2
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 3.19%
ROCE 5.48%
ROIC 3.43%
ROICexc 3.59%
ROICexgc 6.59%
OM 6.73%
PM (TTM) 2.32%
GM 71.66%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.87%
ROIC(5y)3.87%
ROICexc(3y)4.12%
ROICexc(5y)4.87%
ROICexgc(3y)17.94%
ROICexgc(5y)16.07%
ROCE(3y)3.71%
ROCE(5y)5.01%
ROICexgc growth 3Y3.59%
ROICexgc growth 5Y-1.31%
ROICexc growth 3Y-7.11%
ROICexc growth 5Y-4.99%
OM growth 3Y-12.51%
OM growth 5Y-9.94%
PM growth 3Y-15.55%
PM growth 5Y-15.81%
GM growth 3Y-0.57%
GM growth 5Y-0.5%
F-Score7
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 3.58
Cap/Depr 101.93%
Cap/Sales 11.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.65
Altman-Z 1.91
F-Score7
WACC8.11%
ROIC/WACC0.42
Cap/Depr(3y)82.61%
Cap/Depr(5y)85.69%
Cap/Sales(3y)10.64%
Cap/Sales(5y)10.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.61%
EPS 3Y-7.23%
EPS 5Y0.62%
EPS Q2Q%19.15%
EPS Next Y13.97%
EPS Next 2Y14.82%
EPS Next 3Y14.9%
EPS Next 5Y14.32%
Revenue 1Y (TTM)4.44%
Revenue growth 3Y0.96%
Revenue growth 5Y3.2%
Sales Q2Q%2.36%
Revenue Next Year6.01%
Revenue Next 2Y6.22%
Revenue Next 3Y6.45%
Revenue Next 5Y6.89%
EBIT growth 1Y45.07%
EBIT growth 3Y-11.68%
EBIT growth 5Y-7.06%
EBIT Next Year96.6%
EBIT Next 3Y33.66%
EBIT Next 5Y25.87%
FCF growth 1Y-102.72%
FCF growth 3Y-34.34%
FCF growth 5Y-14.37%
OCF growth 1Y-39.92%
OCF growth 3Y-10.42%
OCF growth 5Y-0.91%

NUVASIVE INC / NUVA Fundamental Analysis FAQ

What is the fundamental rating for NUVA stock?

ChartMill assigns a fundamental rating of 4 / 10 to NUVA.


What is the valuation status for NUVA stock?

ChartMill assigns a valuation rating of 5 / 10 to NUVASIVE INC (NUVA). This can be considered as Fairly Valued.


How profitable is NUVASIVE INC (NUVA) stock?

NUVASIVE INC (NUVA) has a profitability rating of 6 / 10.


What is the valuation of NUVASIVE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NUVASIVE INC (NUVA) is 19.88 and the Price/Book (PB) ratio is 2.34.